Skip to main content

Neuromuscular Blocking Agents and Neuromuscular Diseases

  • Chapter
On the Study and Practice of Intravenous Anaesthesia
  • 117 Accesses

Abstract

Acquired neuromuscular diseases or congenital disorders either affect the neuromuscular transmission or the muscle itself. When the neuromuscular transmission is involved, two pathophysiological mechanisms must be distinguished: the abnormality of the nicotinic receptor at the endplate (myasthenia gravis, upregulation of the receptor) and the abnormality of acetylcholine release (Lambert-Eaton myasthenic syndrome, iatrogenic myasthenic syndrome). In both situations pharmacodynamic properties of neuromuscular blocking agents (NMBA) are profoundly affected.1–7

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akpolat N, Tilgen H, Gursoy F, Saydam S, Curel A. Thoracic epidural anaesthesia and analgesia with bupivacaine for transsternal thymectomy for myasthenia gravis. Eur J Anaesthesiol 1997;14:220–3.

    Article  PubMed  CAS  Google Scholar 

  2. Baraka A.Neuromuscular response to succinylcholine-vecuronium sequence in three myasthenic patient undergoing thymectomy. Anesth Analg 1991;72:827–30.

    PubMed  CAS  Google Scholar 

  3. Baraka A. Anaesthesia and myasthenia gravis. Can J Anaseth 1992;39:476–86.

    Article  CAS  Google Scholar 

  4. Begin P, Mathieu J, Almirall J, Grassino A. Relationship between chronic hypercap-nia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 1997;156:133–9

    Article  PubMed  CAS  Google Scholar 

  5. Berroushot J, Baumann I, Kalischewski P, Sterker M, Schneider D. Therapy of myasthenic crisis. Crit Care Med 1997;25:1228–35.

    Article  Google Scholar 

  6. Bevan DR, Bevan J, Donati F. Neuromuscular diseases (pp 414–430). In: Muscles relaxants in clinical anesthesia. Bevan DR, Bevan JC, Donati F eds. Year Book Medical Publishers, Chicago, 1988.

    Google Scholar 

  7. Buzello W, Noeldge G, Krieg N, Brobmann GF. Vecuronium for muscle relaxation in patients with myasthenia gravis. Anesthesiology 1986;64:507–9.

    Article  PubMed  CAS  Google Scholar 

  8. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797–810.

    Article  PubMed  CAS  Google Scholar 

  9. Zulueta JJ, Fanbourg BL Respiratory dysfunction in myasthenia gravis. Clin Chest Med 1994;15:683–91.

    PubMed  CAS  Google Scholar 

  10. Froelich J, Eagle CJ. Anaesthetic management of a patient with myasthenia gravis and tracheal stenosis. Can J Anaesth 1996;43:84–9.

    Article  PubMed  CAS  Google Scholar 

  11. Naguib M, Eldawlatly AA, Ashour M, Bamgboye EA. Multivariate determinants of the need for postoperative ventilation in myasthenia gravis. Can J Anaesth 1996;43: 1006–13.

    Article  PubMed  CAS  Google Scholar 

  12. Evoli A, Batocchi AP, Tonali P. A practical guide to the recognition and management of myasthenia gravis. Drugs 1996;52:662–70.

    Article  PubMed  CAS  Google Scholar 

  13. Mineo TC, Pompeo E, Ambrogi V, Sabato AF, Bernardi G, Casciani CU. Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis. Ann Tho-rac Surg 1996;62:1210–2.

    Article  CAS  Google Scholar 

  14. Eisenkraft JB, Book WJ, Mann SM, Papatestas AE, Hubbard M. Resistance to suc-cinylcholine in myasthenia gravis: a dose-response study. Anesthesiology 1988;69: 760–3.

    Article  PubMed  CAS  Google Scholar 

  15. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM. Up and down regulation of skeletal muscle acetylcholine receptors. Anesthesiology 1992;76:822–43.

    Article  PubMed  CAS  Google Scholar 

  16. Eisenkraft JB, Book WJ, Papatestas AE. Sensitivity to vecuronium in myasthenia gravis: a dose-response study. Can J Anaesth 1990;37:301–6.

    Article  PubMed  CAS  Google Scholar 

  17. Nilsson E, Meretoja OA. Vecuronium dose-response and maintenance requirements in patient with myasthenia gravis. Anesthesiology 1990;73:28–32.

    Article  PubMed  CAS  Google Scholar 

  18. Pelucchi A, Ciceri E, Clementi F, Marazzini L, Foresi A, Sher E. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Am Rev Respir Dis 1993;147:1229–32.

    Article  PubMed  CAS  Google Scholar 

  19. Telford RJ, Hollway TE. The myasthenic syndrome: anaesthesia in a patient treated with 3,4 diaminopyridine. Br J Anaesth 1990;64:363–6.

    Article  PubMed  CAS  Google Scholar 

  20. Wittbrodt ET. Drugs and myasthenia gravis: an update. Arch Intern Med 1997;157: 399–408.

    Article  PubMed  CAS  Google Scholar 

  21. Melacini P, Vianello A, Villanova C, Fanin M, Miorin M, Angelini C, Dalla Volta S. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul disord 1996;6:367–76.

    Article  PubMed  CAS  Google Scholar 

  22. Yanagisawa A, Miyagawa M, Yotsukura M, Tsuya T, Shirato C, Ishihara T, Aoyagi T, Ishikawa K. The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy. Am Heart J 1992;124:1244–50.

    Article  PubMed  CAS  Google Scholar 

  23. Ducceschi V, Nigro G, Sarubbi B, Comi LI, Politano L, Petretta VR, Nardi S, Briglia N, Santogelo L, Nigro G, Lacono A. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. IntJ of Cardiol 1997;59:275–9.

    Article  CAS  Google Scholar 

  24. Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla Volta S. Myocardial involvement is very frequent among patients affected with subclinical Becker’s muscular dystrophy. Circulation 1996;94:3168–75.

    Article  PubMed  CAS  Google Scholar 

  25. Quinlivan RM, Lewis P, Marsden P, Dundas R, Robb SA, Baker E, Maisey M. Cardiac function, metabolism and perfusion in Duchenne and Becker muscular dystrophy. Neuromuscul disord 1996;6:237–46.

    Article  PubMed  CAS  Google Scholar 

  26. Obata R, Yasumi Y, Suzuki A, Nakajima Y, Sato S. Rhabdomyolysis in association with Duchenne’s muscular dystrophy. Can J Anaesth 1999;46:564–6.

    Article  PubMed  CAS  Google Scholar 

  27. Ririe DG, Shapiro F, Sethna NF. The response of patients with Duchenne’s muscular dystrophy to neuromuscular blockade with vecuronium. Anesthesiology 1998;88: 351–4.

    Article  PubMed  CAS  Google Scholar 

  28. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc res 1997;33:13–22.

    Article  PubMed  CAS  Google Scholar 

  29. Rüssel SH, Hirsch NP. Anaesthesia and myotonia. Br J Anaesth 1994;72:210–6.

    Article  Google Scholar 

  30. Smith CE, Donati F, Bevan D. Cumulative dose-response curves for atracurium in patients with myasthenia gravis. Can J Anaesth 1989;36:402–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Plaud, B., Donati, F. (2000). Neuromuscular Blocking Agents and Neuromuscular Diseases. In: Vuyk, J., Engbers, F., Groen-Mulder, S. (eds) On the Study and Practice of Intravenous Anaesthesia. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9604-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-9604-6_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5366-4

  • Online ISBN: 978-94-015-9604-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics